Home Cart Sign in  
Chemical Structure| 914805-33-7 Chemical Structure| 914805-33-7

Structure of Shield-1
CAS No.: 914805-33-7

Chemical Structure| 914805-33-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Shield-1 is an FKBP12 binding protein antagonist that stabilizes FKBP12 mutants, allowing conditional expression, and is an important tool in biological and drug research.

Synonyms: Shld1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Shield-1

CAS No. :914805-33-7
Formula : C42H56N2O10
M.W : 748.90
SMILES Code : O=C([C@H]1N(C([C@H](C2=CC(OC)=C(OC)C(OC)=C2)CC)=O)CCCC1)O[C@@H](C3=CC=CC(OCCN4CCOCC4)=C3)CCC5=CC=C(OC)C(OC)=C5
Synonyms :
Shld1
MDL No. :MFCD18803615

Safety of Shield-1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NIH3T3 cells 1 µM 24 hours To detect fusion protein expression levels by immunoblotting Cell. 2006 Sep 8;126(5):995-1004
HEK-pNF κB-DD-tdTomato-C8 1 µM 18 hours To study the stabilizing effect of Shield-1 on NF-κB-dependent DD-tdTomato expression, results showed that Shield-1 significantly enhanced the fluorescence signal of DD-tdTomato. Int J Mol Sci. 2021 Dec 16;22(24):13530
NIH3T3 cells 3.3 nM (IC50) 24 hours To evaluate the degradation effect of Shield-1 on YFP-LID fusion protein, results showed that Shield-1 induced YFP degradation in a dose-dependent manner. Nat Chem Biol. 2011 Jul 3;7(8):531-7
NIH3T3 cells 1 µM 24 hours To evaluate the effect of Shield-1 on gene expression in NIH3T3 cells, results showed that Shield-1 at 1 μM concentration had only minor effects on a few genes. J Biol Chem. 2007 Aug 24;282(34):24866-72
HeLa Kb cells 5 µM 4 hours Compare antigen presentation efficiency between transfected and virus-infected SCRAP, with transfected cells showing ~8.3-fold higher efficiency Proc Natl Acad Sci U S A. 2012 May 1;109(18):7025-30
EL4 cells 5 µM 4 hours Measure the efficiency of generating Kb–SIINFEKL complexes from nascent vs. retired proteins, showing ∼2% efficiency Proc Natl Acad Sci U S A. 2012 May 1;109(18):7025-30
Human newborn foreskin fibroblasts (HFFs) 1 µM 48 hours Shield-1 was used to stabilize the ddFKBP-tagged UL79 protein, allowing the replication of the recombinant virus AD ddUL79. In the absence of Shield-1, AD ddUL79 failed to replicate, indicating the essential role of UL79 in HCMV replication. J Virol. 2011 May;85(10):4841-52
Human foreskin fibroblasts (HFF) 1 µM 48 hours To stabilize the UL51-FKBP fusion protein and prevent its degradation Vaccines (Basel). 2019 Sep 1;7(3):104

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.34mL

0.27mL

0.13mL

6.68mL

1.34mL

0.67mL

13.35mL

2.67mL

1.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories